152 related articles for article (PubMed ID: 3154830)
1. A study on plasma prostaglandin E2 levels in hepatitis B carriers and patients with chronic active hepatitis.
Kim JH; Heo YS; Ahn KY; Lee YG; Kim DG; Ahn DS
Korean J Intern Med; 1987 Jul; 2(2):170-5. PubMed ID: 3154830
[TBL] [Abstract][Full Text] [Related]
2. [Determination of hepatitis B virus DNA in chronic HbsAg carriers: relation to other markers of viral replication].
Bartolomé Nebreda FJ; Castillo Aguilar I; Mora Pérez I; Gutiez Cuevas J; Hernández-Guio C; Porres Cubero JC; Carreño García V
Rev Clin Esp; 1986 May; 178(9):432-5. PubMed ID: 3738030
[No Abstract] [Full Text] [Related]
3. Serum levels of interferon-alpha and -gamma in acute and chronic hepatitis B virus infection.
Chu CM; Sheen IS; Yeh CT; Hsieh SY; Tsai SL; Liaw YF
Dig Dis Sci; 1995 Oct; 40(10):2107-12. PubMed ID: 7587774
[TBL] [Abstract][Full Text] [Related]
4. [Levels of serum lipid peroxide in patients with viral hepatitis and its clinical significance].
Fan XG; Zhang Z
Zhonghua Yi Xue Za Zhi; 1988 Feb; 68(2):76-8. PubMed ID: 3136882
[No Abstract] [Full Text] [Related]
5. Trial of specific antigen-mediated leukocyte adherence inhibition test in patients with chronic active hepatitis and hepatitis B carrier.
Oh YI; Song SH; Kim WH; Cho KH; An JK; Ahn DS
Korean J Intern Med; 1986 Jul; 1(2):158-65. PubMed ID: 3154610
[TBL] [Abstract][Full Text] [Related]
6. Chronicity rate of hepatitis B virus infection in the families of 60 hepatitis B surface antigen positive chronic carrier children: role of horizontal transmission.
Vegnente A; Iorio R; Guida S; Cimmino L
Eur J Pediatr; 1992 Mar; 151(3):188-91. PubMed ID: 1601010
[TBL] [Abstract][Full Text] [Related]
7. [Distribution of the antigen of hepatitis B virus in liver tissue in healthy carriers and in patients with chronic active and acute hepatitis].
Garciá-Ruiz H; Sotto-Escobar A; Gra-Oramas B
Rev Gastroenterol Mex; 1989; 54(2):87-90. PubMed ID: 2772481
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic significance of anti-HBc IgM (RIA) in healthy HBsAg carriers and in chronic hepatitis B.
Surrenti C; Ambu S; Patussi V; Milani S; Casini A; Zacchi P; Ceccatelli P; Cefaratti C; D'Agata A
J Med Virol; 1986 Mar; 18(3):229-34. PubMed ID: 3701301
[TBL] [Abstract][Full Text] [Related]
9. [Changes of HBeAg/anti-HBeAb system in chronic type B hepatitis, especially acute hepatitis from HBsAg carriers and persistent hepatitis].
Kasajima M
Nihon Shokakibyo Gakkai Zasshi; 1984 Jul; 81(7):1574-81. PubMed ID: 6492455
[No Abstract] [Full Text] [Related]
10. Hepatitis B serological patterns of asymptomatic carriers in an endemic region and evaluation of blood plasma as a source of hepatitis B vaccine.
Yoshida CF; Camargo IF; Mercadante LA; Gaspar AM; Gomes DF; Schatzmayr HG
Vaccine; 1986 Dec; 4(4):253-6. PubMed ID: 3799019
[TBL] [Abstract][Full Text] [Related]
11. Redevelopment of hepatitis B surface antigen after renal transplantation.
Marcellin P; Giostra E; Martinot-Peignoux M; Loriot MA; Jaegle ML; Wolf P; Degott C; Degos F; Benhamou JP
Gastroenterology; 1991 May; 100(5 Pt 1):1432-4. PubMed ID: 2013388
[TBL] [Abstract][Full Text] [Related]
12. Chronic type B hepatitis and the "healthy" HBsAg carrier state.
Hoofnagle JH; Shafritz DA; Popper H
Hepatology; 1987; 7(4):758-63. PubMed ID: 3301618
[No Abstract] [Full Text] [Related]
13. [The treatment of patients with chronic persistent hepatitis B with interferon preparations].
Kokoreva LN; Zmyzgova AV; Shalygina NB
Ter Arkh; 1995; 67(6):43-5. PubMed ID: 7667778
[TBL] [Abstract][Full Text] [Related]
14. Suppressor T-cell activity in chronic hepatitis B-virus infection: relationship with the presence of HBV-DNA in serum.
Iraburu M; Civeira MP; Serrano M; Morte S; Castilla A; Prieto J
J Med Virol; 1989 Jan; 27(1):39-43. PubMed ID: 2522145
[TBL] [Abstract][Full Text] [Related]
15. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
Kokoreva LN; Zmyzgova AV; Shalygina NB
Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
[TBL] [Abstract][Full Text] [Related]
16. The absence of hepatitis B virus DNA in hepatitis B e antigen positive sera from chronic hepatitis B surface antigen carriers in China.
Scott JS; Pan PE; Pace RA; Sloots TP; Cooksley WG
J Med Virol; 1990 Feb; 30(2):103-6. PubMed ID: 2313271
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic significance of erythrocyte carbohydrate metabolism indicators in chronic subclinical HBsAG carrier state].
Levina LD; Bezuglova IA; Proĭdakov MA
Klin Med (Mosk); 1995; 73(6):26-8. PubMed ID: 8691773
[TBL] [Abstract][Full Text] [Related]
18. [Lymphocyte populations in patients with hepatitis caused by B virus: relation to other etiologies].
Carreño García V; Gutiez Cuevas J; Mora Pérez I; Porres Cubero JC; Hernández Guio C
Rev Esp Enferm Apar Dig; 1986 Dec; 70(6):493-6. PubMed ID: 3494279
[No Abstract] [Full Text] [Related]
19. Impaired interleukin-2 receptor expression on lymphocytes from patients with chronic active hepatitis type B.
Ahn DS; Jang HC; Ahn JK; Yim CY; Kim DG
Korean J Intern Med; 1989 Jan; 4(1):34-40. PubMed ID: 2487403
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of chronic hepatitis in viral hepatitis B. Hypotheses as rational principles in immune modulating and virostatic therapy of chronic hepatitis B].
Markus R; Baumgaŕten R; Fengler JD
Z Arztl Fortbild (Jena); 1988; 82(8):363-8. PubMed ID: 3043935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
